share_log

Inhibrx Biosciences Q2 EPS $125.48, Sales $100.00K Up From $30.00K YoY

Inhibrx Biosciences Q2 EPS $125.48, Sales $100.00K Up From $30.00K YoY

Inhibrx生物科技第二季度每股收益爲125.48美元,銷售額爲10萬美元,同比增長了3萬美元。
Benzinga ·  08/14 15:24

Inhibrx Biosciences (NASDAQ:INBX) reported quarterly earnings of $125.48 per share. This is a 3011.37 percent increase over losses of $(4.31) per share from the same period last year. The company reported $100.00 thousand in sales this quarter. This is a 233.33 percent increase over sales of $30.00 thousand the same period last year.

Inhibrx生物科學公司(納斯達克:INBX)報告每股收益爲125.48美元的季度收益。這比去年同期每股虧損4.31美元增長了3011.37%。該公司本季度銷售額爲10萬美元。這比去年同期的3萬美元增長了233.33%。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論